Precision medicine for depressive disorders
Using genomic information to study why individuals respond differently to antidepressant medications and rTMS
Building prediction models for treatment response and developing a clinical decision support system accordingly
Developing next-generation TMS treatment system.
Comorbidity and prognosis of methamphetamine use
Identifying the prognostic factors and characteristics predicting physical and psychiatric complications in methamphetamine users
GWAS of methamphetamine use related phenotypes
Studying the genetic overlap between methamphetamine use and other psychiatric disorders
GWAS and post-GWAS analysis
Biobank-scale genome-wide and phenome-wide analyses
Global Biobank Meta-analysis Initiative
Polygenic scoring and causal mediation analysis
Combing polygenic profiling and causal mediation methods to identify the causal relationship between two genetically correlated phenotypes and their shared genetic factors
Mendelian randomization
Using genetic variation of known function to examine the causal effect of a modifiable exposure on disease in observational studies